CNS Complications of Radiotherapy and ChemotherapyLancet 374:1639-1651, Soussain,C.,et al, 2009
Controversy and Progress in Alzheimers Disease - FDA Approval of AducanumabNEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021